WVE - CIK 0001631574
The table below shows Wave Life Sciences Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $544.59M | $196.22M | $208.48M | $243.07M | $310.95M | $153.96M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $0.00 | $10.00M | $1.62M | $1.42M | $0.00 | $1.29M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $561.27M |
| $215.49M |
| $223.56M |
| $257.98M |
| $324.51M |
| $172.07M |
| Property, plant & equipment | $7.08M | $8.20M | $9.04M | $9.57M | $10.93M | $11.78M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $583.54M | $241.38M | $252.35M | $288.34M | $358.50M | $208.82M |
| Accounts payable | $19.06M | $14.49M | $14.66M | $14.36M | $12.78M | $18.15M |
| Total current liabilities | $49.83M | $85.90M | $87.41M | $87.37M | $170.73M | $173.13M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $71.81M | $108.95M | $105.22M | $108.67M | $208.99M | $204.42M |
| Retained earnings | -$1.35B | -$1.27B | -$1.22B | -$1.17B | -$1.15B | -$1.09B |
| Total equity | $511.73M | $124.55M | $139.27M | $171.80M | $141.64M | -$3.48M |